1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. OrganiGram Holdings Inc.
  6. Summary
    OGI   CA68620P1018

ORGANIGRAM HOLDINGS INC.

(OGI)
  Report
Delayed Toronto Stock Exchange  -  04:00 2022-06-30 pm EDT
1.180 CAD   -4.07%
06/24OrganiGram Agrees to Proposed $2.3 Million Settlement Related to Recalled Medical Cannibas Lawsuit
MT
06/24ORGANIGRAM : Proposed Settlement Reached in 2016 Class Action - Form 6-K
PU
06/23Proposed Settlement Reached in 2016 Class Action
BU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
06/24/2022 06/27/2022 06/28/2022 06/29/2022 06/30/2022 Date
1.37(c) 1.39(c) 1.31(c) 1.23(c) 1.18(c) Last
707 602 673 270 546 241 640 209 373 221 Volume
+5.38% +1.46% -5.76% -6.11% -4.07% Change
More quotes
Estimated financial data (e)
Sales 2022 134 M 103 M 103 M
Net income 2022 -18,6 M -14,4 M -14,4 M
Net cash position 2022 116 M 89,6 M 89,6 M
P/E ratio 2022 -13,3x
Yield 2022 -
Sales 2023 180 M 139 M 139 M
Net income 2023 -17,0 M -13,2 M -13,2 M
Net cash position 2023 96,5 M 74,7 M 74,7 M
P/E ratio 2023 -15,5x
Yield 2023 -
Capitalization 370 M 287 M 287 M
EV / Sales 2022 1,90x
EV / Sales 2023 1,52x
Nbr of Employees 841
Free-Float 81,3%
More Financials
Company
OrganiGram Holdings Inc. is a Canada-based company, which operates through its subsidiaries, Organigram Inc (Organigram) and Laurentian Organic Inc. Organigram is a licensed producer of cannabis and extract-based products. The Company is focused on producing, indoor-grown cannabis for patients and adult recreational consumers in Canada. Organigram is permitted to possess, produce, sell, provide, ship, deliver and... 
More about the company
Ratings of OrganiGram Holdings Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ORGANIGRAM HOLDINGS INC.
06/24OrganiGram Agrees to Proposed $2.3 Million Settlement Related to Recalled Medical Canni..
MT
06/24ORGANIGRAM : Proposed Settlement Reached in 2016 Class Action - Form 6-K
PU
06/23Proposed Settlement Reached in 2016 Class Action
BU
06/02ORGANIGRAM : Annual Information Form
PU
04/13Organigram Holdings Shares Rise 4%, Upgraded to Outperform at ATB Capital
MT
04/12Cannabis company Organigram reports Q2 loss, more than doubles revenue
AQ
04/12Organigram Up More Than 5%, Was Even Higher on TSX After Q2
MT
04/12TRANSCRIPT : OrganiGram Holdings Inc., Q2 2022 Earnings Call, Apr 12, 2022
CI
04/12ORGANIGRAM : Fiscal Q2 Earnings Snapshot
AQ
04/12Organigram Reports Narrower Q2 Loss of $4.05 Million; Q2 Revenue of $31.84 Million Beat..
MT
04/12OrganiGram Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months..
CI
04/12OrganiGram Fiscal Q2 Loss Narrows as Revenue Rises; Issues Fiscal Q3 Guidance
MT
04/12NORTH AMERICAN MORNING BRIEFING : Stocks Waver, -3-
DJ
04/12ORGANIGRAM BRIEF : Q2 Net loss (4,047) Milliion
MT
04/12ORGANIGRAM BRIEF : Cites a top 3 national market share position among Canadian LPs.
MT
More news
News in other languages on ORGANIGRAM HOLDINGS INC.
06/24OrganiGram accepte un règlement proposé de 2,3 millions de dollars lié à une action en ..
04/12Organigram en hausse de plus de 5 %, le TSX était encore plus haut après le T2
04/12Organigram annonce une perte réduite de 4,05 millions de dollars au deuxième trimestre ..
04/12OrganiGram Holdings Inc. annonce ses résultats pour le deuxième trimestre et le semestr..
04/12OrganiGram réduit sa perte au deuxième trimestre et augmente son chiffre d'affaires, et..
More news
Analyst Recommendations on ORGANIGRAM HOLDINGS INC.
More recommendations
Chart ORGANIGRAM HOLDINGS INC.
Duration : Period :
OrganiGram Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ORGANIGRAM HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 1,18 CAD
Average target price 2,97 CAD
Spread / Average Target 152%
EPS Revisions
Managers and Directors
Beena G. Goldenberg Chief Executive Officer & Director
Derrick W. West Chief Financial Officer
Peter Amirault Executive Chairman
Nathalie Batten Vice President-Operations
Dexter D. S. John Independent Director
Sector and Competitors